Results 131 to 140 of about 8,213 (210)

Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider Survey. [PDF]

Cancer Med
Lacey C, Clark K, Debacker JR, Stuehm H, Hungerford M, Milnes T, Johansson K, Mannino R, Graff JN, Konrad-Martin D.   +9 more
europepmc   +1 more source

Hearing Loss in Systemic Lupus Erythematosus: a Systematic Review. [PDF]

Maedica (Bucur)
Hanna Y, Tlais M, Natour D, Mazraani Y, Obeid N, Sarraf G, Zalzali I, Moghnie Y, Harouny T, Chebbo H, Farhat H.   +10 more
europepmc   +1 more source

Scaling-up diagnosis and treatment of drug-resistant tuberculosis in Khayelitsha, South Africa [PDF]

, 2011
MSF OCB, MSF South Africa
core   +1 more source

Building a translational research program in Neurotology at University of Kansas Medical Center [PDF]

, 2015
Staecker, Hinrich L., Sykes, Kevin L.
core   +2 more sources

Pharmacogenetic strategies to mitigate cisplatin-induced ototoxicity in head and neck cancer: A cost-minimization analysis with the use of GSTP1 c.313A>G genotyping. [PDF]

PLoS One
Macedo LT, Ferrari VE, Dias Costa EF, Lourenço GJ, Calonga L, Castilho AM, Chone CT, Passos Lima CS.   +7 more
europepmc   +1 more source

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study. [PDF]

EClinicalMedicine
Sanchez VA, Dinh PC, Monahan PO, Fung C, Althouse S, Stump T, Rooker J, Dolan ME, Feldman DR, Hamilton RJ, Pierorazio PM, Martin NE, Huddart R, Kollmannsberger C, Root J, Sesso HD, Weinzierl M, Einhorn LH, Frisina RD, Travis LB.   +19 more
europepmc   +1 more source

From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy. [PDF]

Pharmaceuticals (Basel)
Iațentiuc A, Cozma SR, Frăsinariu OE, Miron IC, Iațentiuc IM, Dima-Cozma LC, Olariu R, Postolache A, Buga AL, Stingheriu A, Boéchat E, Bitere-Popa OR.   +11 more
europepmc   +1 more source

Distortion product otoacoustic emission (DPOAE) reveals hearing loss up to 16 kHz in pediatric chemotherapy patients. [PDF]

Sci Rep
Hecker DJ, Remke MKH, Linxweiler M, Furtwängler R, Akrasu Y, Schöndorf D, Graf N, Krieter D, Oberkircher N, Schick B, Bozzato A, Simon A.   +11 more
europepmc   +1 more source

Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience. [PDF]

J Natl Cancer Inst
Sousa LG, Edward Bates J, Anand P, Caudell JJ, Colevas AD, Runge CL, Sharon JD, Awan M, Beadle BM, Choe JH, Gidley PW, Harari PM, Henson C, Katzel JA, Lee NY, McDowell L, Mell LK, Nader ME, Rudra S, Wang K, Yang G, Yom SS, Wise-Draper TM.   +22 more
europepmc   +1 more source

In Silico Hazard Assessment of Ototoxicants Through Machine Learning and Computational Systems Biology. [PDF]

Toxics
Luan S, Ji C, Zarus GM, Reh CM, Ruiz P.
europepmc   +1 more source